| 1 | 
                
                    Azathioprine
                
             | 3件:  Azathioprine Azathioprine; Azatioprina; Imuran | 2件:  D00238 
                
                    D00238
                
            , 
                
                    D03033
                
             | - | - | 21件:  6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162 | 
| 2 | 
                
                    Colchicine
                
             | 2件:  COLCHICINA COLCHICINA; Colchicine | 1件:  D00570 
                
                    D00570
                
             | 9件:  TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | 10件:  Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 7件:  2 2, 42, 46, 56, 93, 210, 266 | 
| 3 | 
                
                    Cyclophosphamide
                
             | 6件:  Ciclofosfamida Ciclofosfamida; Ciclofosfamide; Cyclophosphamid; Cyclophosphamide; Cyclophosphamidum; Cytoxan | 2件:  D00287 
                
                    D00287
                
            , 
                
                    D07760
                
             | - | - | 45件:  11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 | 
| 4 | 
                
                    Cyclosporine
                
             | 10件:  Ciclosporin Ciclosporin; Ciclosporina; Ciclosporine; Cyclosporin; Cyclosporin A; Cyclosporine; Cyclosporine A; Ikervis; NEORAL; RESTASIS | 1件:  D00184 
                
                    D00184
                
             | 5件:  PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件:  Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 44件:  11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 | 
| 5 | 
                
                    Dapsone
                
             | 1件:  Dapsone Dapsone | 1件:  D00592 
                
                    D00592
                
             | - | - | 6件:  35 35, 42, 60, 84, 90, 162 | 
| 6 | 
                
                    Filgrastim
                
             | 7件:  Filgrastim Filgrastim; Filgrastim Hexal; G-CSF; Granulocyte Colony Stimulating Factor; NEUPOGEN; TEVAGRASTIM; Zarzio | 1件:  D03235 
                
                    D03235
                
             | 1件:  CSF3R CSF3R 💬 | 5件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 34件:  2 2, 6, 11, 13, 16, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 | 
| 7 | 
                
                    Infliximab
                
             | 6件:  Flixabi Flixabi; Inflectra; INFLIXIMAB; REMICADE; Remsima; Zessly | 1件:  D02598 
                
                    D02598
                
             | 1件:  TNF TNF 💬 | 67件:  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 27件:  35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 | 
| 8 | 
                
                    Lamivudine
                
             | 4件:  COMBIVIR COMBIVIR; Epivir; Lamivudine; Triumeq | 1件:  D00353 
                
                    D00353
                
             | - | - | 7件:  2 2, 26, 42, 46, 135, 265, 325 | 
| 9 | 
                
                    Methotrexate
                
             | 6件:  Methotrexat Methotrexat; METHOTREXATE; METHOTREXATE SODIUM; Metoject; METOTREXATO; Méthotrexate | 2件:  D00142 
                
                    D00142
                
            , 
                
                    D02115
                
             | 2件:  DHFR DHFR, DHFR2 💬 | 5件:  Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 38件:  11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 | 
| 10 | 
                
                    Methylprednisolone
                
             | 4件:  Medrol Medrol; Methylprednisolon; Methylprednisolone; METHYLPREDNISOLONE ACETATE | 6件:  D00407 
                
                    D00407
                
            , 
                
                    D00751
                
            , 
                
                    D00979
                
            , 
                
                    D05000
                
            , 
                
                    D05001
                
            , 
                
                    D05002
                
             | 1件:  NR3C1 NR3C1 💬 | 1件:  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 48件:  2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 | 
| 11 | 
                
                    Mycophenolate mofetil
                
             | 3件:  CELLCEPT CELLCEPT; Mycophenolate Mofetil; Mycophenolate mofetil TEVA | 3件:  D00752 
                
                    D00752
                
            , 
                
                    D05094
                
            , 
                
                    D05095
                
             | 2件:  IMPDH1 IMPDH1, IMPDH2 💬 | 3件:  Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 34件:  2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 | 
| 12 | 
                
                    Mycophenolic acid
                
             | 5件:  Acido Micofenolico Acido Micofenolico; MICOFENOLICO ACIDO; Mycophenolate; Mycophenolic acid; Myfortic | 1件:  D05096 
                
                    D05096
                
             | 2件:  IMPDH1 IMPDH1, IMPDH2 💬 | 3件:  Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 36件:  2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 | 
| 13 | 
                
                    Naltrexone
                
             | 2件:  Naltrexone Naltrexone; Naltrexone Hydrochloride | 2件:  D02095 
                
                    D02095
                
            , 
                
                    D05113
                
             | 3件:  OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件:  Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 13件:  6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 | 
| 14 | 
                
                    Prednisone
                
             | 3件:  Prednisona Prednisona; Prednisone; RAYOS | 1件:  D00473 
                
                    D00473
                
             | 1件:  NR3C1 NR3C1 💬 | 1件:  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 48件:  2 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 127, 162, 164, 205, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 | 
| 15 | 
                
                    Rituximab
                
             | 6件:  MABTHERA MABTHERA; Rituxan; Rituximab; Rixathon; Ruxience; Truxima | 1件:  D02994 
                
                    D02994
                
             | 1件:  MS4A1 MS4A1 💬 | 1件:  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 49件:  6 6, 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 127, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 | 
| 16 | 
                
                    Tocilizumab
                
             | 3件:  ACTEMRA ACTEMRA; RoActemra; TOCILIZUMAB | 1件:  D02596 
                
                    D02596
                
             | 1件:  IL6R IL6R 💬 | 12件:  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 21件:  2 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 |